ShortDax X5 AR Total Return EUR News - DL3J

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

StemCells, Inc. Reports Second Quarter Financial Results

NEWARK, Calif., July 28, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company...

StemCells, Inc. Announces Webcast to Discuss Second Quarter Financial Results and Business Update

NEWARK, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company...

New Publication Validates StemCells, Inc.'s SC Proven(R) Reagents for Automated Production and Cell-Based Screening

NEWARK, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD) announced today publication...

StemCells, Inc. Regains Compliance for Continued NASDAQ Global Market Listing

NEWARK, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEMD), a leading stem cell company...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...

Stem-Cell Stocks May Now Be Worth The Risk

After years of being swatted about like ping-pong balls, are stem-cell stocks now worth a second look? Perhaps no other medical subsector has had...

- Amended Statement of Ownership (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) STEMCELLS INC...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

ShortDax X5 AR Total Return EUR (DL3J)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

DL3J News

- Current report filing (8-K)

StemCells, Inc. Reports Second Quarter Financial Results

StemCells, Inc. Announces Webcast to Discuss Second Quarter Financial Results and Business Update

New Publication Validates StemCells, Inc.'s SC Proven(R) Reagents for Automated Production and Cell-Based Screening

StemCells, Inc. Regains Compliance for Continued NASDAQ Global Market Listing

- Current report filing (8-K)

Stem-Cell Stocks May Now Be Worth The Risk

- Amended Statement of Ownership (SC 13G/A)

DL3J Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

ShortDax X5 AR Total Return EUR (DL3J) News

ShortDax X5 AR Total Return EUR (DL3J)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

DL3J News

- Current report filing (8-K)

StemCells, Inc. Reports Second Quarter Financial Results

StemCells, Inc. Announces Webcast to Discuss Second Quarter Financial Results and Business Update

New Publication Validates StemCells, Inc.'s SC Proven(R) Reagents for Automated Production and Cell-Based Screening

StemCells, Inc. Regains Compliance for Continued NASDAQ Global Market Listing

- Current report filing (8-K)

Stem-Cell Stocks May Now Be Worth The Risk

- Amended Statement of Ownership (SC 13G/A)

DL3J Discussion

Your Recent History